TABLE 5.

Univariate and multivariate logistic regression analyses for high GS.

Variables	Univariate		p-value	Multivariate		p-value
	OR	95% CI		OR	95% CI
Age (years)	1.01	0.99–1.02	0.560
Male, n (%)	1.40	0.97–2.01	0.069	1.39	0.94–2.06	0.097
LVEF (%)	0.48	0.10–2.23	0.347
SBP (mmHg)	1.00	0.99–1.01	0.559
DBP (mmHg)	1.00	0.98–1.01	0.614
Current smoking	0.89	0.52–1.53	0.664
FH-CAD	3.29	2.32–4.67	<0.001	3.21	2.24–4.61	<0.001
Glucose metabolism status
NGR	Reference			Reference
PDM	1.33	0.82–2.16	0.246	1.16	0.68–1.97	0.583
DM	1.85	1.29–2.67	0.001	1.65	0.89–3.04	0.113
Hypertension	0.90	0.64–1.26	0.537
TC (mg/dL)	1.00	1.00–1.01	0.356
LDL-C (mg/dL)	1.01	1.00–1.01	0.028	1.01	1.00–1.01	0.031
eGFR (mL/min/1.73 m2)	1.00	0.99–1.01	0.941
UA (μmol/L)	1.00	1.00–1.00	0.500
Single antiplatelet therapy	0.89	0.59–1.33	0.561
Dual antiplatelet therapy	3.59	1.39–9.25	0.008	3.77	1.37–10.40	0.010
Beta-blocker	0.77	0.39–1.52	0.444
ACEI/ARB	0.90	0.50–1.60	0.710
Statin	0.77	0.50–1.19	0.234
Insulin	1.63	1.05–2.52	0.029	1.21	0.66–2.24	0.537
Metformin	0.98	0.57–1.68	0.942
Other hypoglycemic drugs	1.64	1.07–2.51	0.023	0.89	0.48–1.64	0.703
TG/HDL-C ratio	1.13	0.97–1.32	0.113
TyG index	1.15	0.98–1.35	0.091
METS-IR	1.32	1.12–1.55	0.001	1.22	1.02–1.47	0.032

p-values in bold are <0.05.

OR, odds ratio; CI, confidence interval; SBP, systolic blood pressure; DBP, diastolic blood pressure; LVEF, left ventricular ejection fraction; FH-CAD, family history of coronary artery disease; NGR, normal glucose regulation; PDM, prediabetes mellitus; DM, diabetes mellitus; FPG, fasting plasma glucose; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein-cholesterol; HDL-C, high-density lipoprotein-cholesterol; eGFR, estimated glomerular filtration rate; UA, uric acid; ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; TG/HDL-C ratio, the ratio of triglycerides to high-density lipoprotein cholesterol; TyG index, triglyceride and glucose index; METS-IR, metabolic score for insulin resistance.